Inam Butt and the Missed Therapeutic Window: When a Medical File Cannot Save a Silver Medal

Inam Butt's eyes had been hurting for months before he stepped onto the podium to collect his silver medal at the Asian Beach Games. It was the kind of pain professional athletes learn to hide — not a hamstring tear visible to the naked eye, but a dull ache on the inside, forcing a former world champion to find a doctor. The prescription he received treated that eye condition. But in the language of the International Testing Agency (ITA), a medically correct prescription can still become a violation if the paperwork cannot keep pace. When the positive sample surfaced, Butt's story turned: from a veteran grappler newly appointed as national team coach, he became a name on a doping investigation list.

Inam Butt is no stranger to the world of beach wrestling. He was once a world champion in the discipline governed by United World Wrestling (UWW) — a sport bound to the WADA anti-doping framework, not run on the commercial logic of MMA or professional boxing. At an age described as veteran, Butt had already built a second career: national squad coach, secretary of the Pakistan Wrestling Federation (PWF), and chairman of the Athletes Commission of the Pakistan Olympic Association (POA).

Three roles at once. That is a figure worth pausing on longer than most fans allow. In many countries with small sports systems, one individual carries the athlete, coach, and official seats simultaneously — not necessarily out of ambition, but because the talent pool is too shallow to fill enough chairs. That structure creates a governance blind spot: when the person holding three roles enters an investigation into himself, who sits in the judgment seat?

The event took place at the Asian Beach Games. Butt won silver in April. Afterward, a test returned positive for a substance linked to eye treatment. In the file, the ITA accepted that the use was therapeutic, not performance-enhancing. That is the life-or-death boundary between a procedural error and cheating.

The core of the story lies in a paperwork gap. The ITA accepted that Butt used the medication to treat his eyes — not to boost performance — but he failed to obtain a Therapeutic Use Exemption (TUE) in time. Under the WADA framework, using a prohibited substance for legitimate medical reasons is entirely permitted, provided the athlete holds a valid TUE before use. When the paperwork arrives late, the medical truth can no longer rescue the procedure.

This is where fans often misunderstand. They think anti-doping is a battle between good drugs and bad drugs. It is not. It is a battle between paperwork on time and paperwork out of time. A prescription correct in every clinical detail, signed by a licensed physician, can still land an athlete on the violation list if the administrative steps were not completed before the substance entered the body.

Reports say the ITA granted Butt permission to use this medication for a one-year period. That is an awkward detail. If a one-year TUE already existed, why would a failure to obtain a timely TUE exist? The two facts can only be reconciled if that permission covered a different time window, or was granted retroactively after the matter surfaced. In other words, what is called a permit may in substance be a leniency ruling dressed up as procedure.

The expected sanction reinforces that direction. Sources say Butt faces a suspension of roughly two months, backdated to April — the month of the Asian Beach Games. A short, backdated ban is the classic signature of what the WADA Code calls no significant fault or negligence. This is not the outcome of an athlete cleared, but of an athlete mitigated.

But here is the part the media underplays: even though the ITA accepts the therapeutic explanation, the silver medal will still be stripped, because the strict-liability principle in anti-doping does not allow a medical exception to automatically erase a competition result. This is the cruelest point of the system. The body can be understood; the scoreboard cannot. A crack never heals, it is merely painted over in a better color.

That framework yields three scenarios. Worst case: the ITA treats the late TUE as ordinary negligence, leading to a suspension of months or years, formal forfeiture of the medal, and severe reputational damage. The central case, per sources: a two-month backdated ban, recognition of the medical explanation, loss of the silver but preserved eligibility for the Asian Games. Best case: a reprimand, no period of ineligibility, if the ITA fully credits the medical basis — but even then, the medal loss still happens.

The way most outlets tell this story irritates me. Headlines tend to read relief for Inam Butt or a lenient sanction is coming. That frame turns a doping case into an escape story. But for someone who writes about injuries and medical files, something feels off.

Butt has not escaped. He will lose his Asian Beach Games silver. He voluntarily stepped down from the PWF secretary post and the POA Athletes Commission chair during the investigation, citing the sport's interests and impartiality. That is a commendable act of governance hygiene — but it is also an admission that sitting in a position of power while under investigation is unacceptable.

The deeper problem is structural. I trust a medical file more than any contract ever printed in ink. But a medical file only has value when the system allows it to be created on time. In small federations, where one person competes, coaches, and administers all at once, the TUE paperwork burden easily falls into a responsibility gap. No one is held at fault, because no one was assigned the task. Until the sample turns positive, and suddenly everything lands on the athlete's head.

The counterintuitive point: a short ban is not good news. It is a sign that the system accepts the error was real but not serious. For an athlete past his peak and transitioning into a coaching role — which in Pakistan is often tied to stipends and medal-based positions — losing the silver may be a more concrete material loss than the suspension itself. The market has a window, the human body has a death door. Here, that window closed back in April, and Butt only learned of it when he looked at the test result.

Inam Butt's story will close in the next few weeks, when the ITA issues its formal ruling. But the question it leaves behind does not close with the sanction. A sports system that hands three roles to one person, then hands that same person the duty to remember every medical document deadline, is already designing the next cracks. For Butt, it was his eyes and a medal. For the next person, it may be a knee, a hamstring, another therapeutic window missed in silence. The lesson is not whether he receives a reduction, but this: in this game, what gets remembered is not the pain, but the paper that proves it.